ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2019 and some content may be unavailable. To unlock all content for 2019, please visit the archives.

Abstract: FR-PO356

Impact of Periostin in Aging Kidney

Session Information

  • CKD: Mechanisms - II
    November 08, 2019 | Location: Exhibit Hall, Walter E. Washington Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: CKD (Non-Dialysis)

  • 2103 CKD (Non-Dialysis): Mechanisms

Authors

  • Ryoo, Jiwon, Seoul St. Mary's Hosp, Catholic Univ of Korea, Seoul, Korea (the Republic of)
  • Kwon, Yun Jae, Seoul St. Mary's Hosp, Catholic Univ of Korea, Seoul, Korea (the Republic of)
  • Kim, Hyung Duk, Seoul St. Mary's Hosp, Catholic Univ of Korea, Seoul, Korea (the Republic of)
  • Kim, Eun Nim, The Catholic University of Korea, Seoul, Korea (the Republic of)
  • Jin, Yongjie, The Catholic University of Korea, Seoul, Korea (the Republic of)
  • Lim, Ji Hee, The Catholic University of Korea, Seoul, Korea (the Republic of)
  • Kim, Yaeni, Seoul St. Mary's Hosp, Catholic Univ of Korea, Seoul, Korea (the Republic of)
  • Park, Cheol Whee, Seoul St. Mary's Hosp, Catholic Univ of Korea, Seoul, Korea (the Republic of)
  • Choi, Bumsoon, Division of Nephrology, Department of Internal Medicine, Seoul, Korea (the Republic of)
Background

Periostin is a matricellular protein which plays important role in tissue adaptation to injury. In kidney disease, periostin is known to be highly expressed in tubulointerstitial fibrosis and correlated with renal function inversely. In this study, we investigated the effect of periostin in aging process and progressive renal interstitial fibrosis.

Methods

1. UUO model
We conducted unilateral ureteral obstruction (UUO) surgery in wild type (WT) mice and periostin knockout (KO) mice. And compared interstitial fibrosis and pericyte changes.

2. Aging model
We compared interstitial fibrosis and changes of pericytes in 4 groups; WT young age group, WT old age group, periostin KO young age group and periostin KO old age group.

Results

In UUO model, periostin KO mice shows less interstitial fibrosis and increased number of pericytes.
And periostin KO aging mice shows attenuated fibrosis and abundant pericytes compared to WT aging mice.

Conclusion

Periostin inhibition ameliorated renal interstitial fibrosis in UUO model and aging process. It is thought that it affects pericyte and shows a reno-protective effect.

Figure 1. Changes of pericytes in UUO of periostin KO mouse

Figuer 2. Changes of fibrosis and pericytes in aging periostin KO mouse